FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation

Jinju Park(Seoul National University), Byung Lan Lee(Seoul National University)

Cancer Research and Treatment

March 26, 2017

10.4143/crt.2016.580

Cited by 41

Related Papers

Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1

|Cancer Research and Treatment|2015|59

The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway

|Gastric Cancer|2013|55

Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules

|BMC Cancer|2011|54

Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression

|British Journal of Cancer|2015|36

A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion

|BMC Gastroenterology|2013|26